Patients with encrusted ureteral stents can be treated by a single session combined endourological approach.


Journal

International braz j urol : official journal of the Brazilian Society of Urology
ISSN: 1677-6119
Titre abrégé: Int Braz J Urol
Pays: Brazil
ID NLM: 101158091

Informations de publication

Date de publication:
Historique:
received: 24 06 2020
accepted: 22 08 2020
entrez: 23 2 2021
pubmed: 24 2 2021
medline: 24 4 2021
Statut: ppublish

Résumé

To describe our experience in the management of retained encrusted ureteral stents using a single session combined endourological approach. Patients with retained encrusted ureteral stents who had been submitted to a single session combined endourological approach from June 2010 to June 2018 were prospectively evaluated. Patients were divided according to the Forgotten-Encrusted-Calcified (FECal) classification. The stone burden, surgical intervention, number of interventions until stone free status, operation time, hospital stay, complications, stone analysis, and stone-free rate were compared between groups. ANOVA was used to compare numerical variables, and the Mann-Whitney or Chi-square test to compare categorical variables between groups. We evaluated 50 patients with a mean follow-up of 2.9±1.4 years (mean±SD). The groups were comparable in terms of age, sex, laterality, BMI, comorbidities, ASA, reason for stent passage, and indwelling time. The stone burden was higher for grades IV and V (p=0.027). Percutaneous nephrolithotomy was the most common procedure (p=0.004) for grades IV and V. The number of procedures until the patients were stone-free was 1.92±1.40, and the hospital stay (4.2±2.5 days), complications (22%), and stone analysis (66% calcium oxalate) were similar between groups. The stone-free rate was lower in grades III to V (60%, 54.5%, and 50%). The endoscopic combined approach in the supine position is a safe and feasible technique that allows removal of retained and encrusted stents in a single procedure. The FECal classification seems to be useful for surgical planning.

Identifiants

pubmed: 33621006
doi: 10.1590/S1677-5538.IBJU.2020.0511
pii: IBJU20200511
pmc: PMC7993973
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

574-583

Informations de copyright

Copyright® by the International Brazilian Journal of Urology.

Déclaration de conflit d'intérêts

None declared.

Références

J Endourol. 2013 Jul;27(7):845-9
pubmed: 23373958
J Endourol. 2018 Apr;32(4):350-353
pubmed: 29385812
Urology. 2016 Nov;97:51-55
pubmed: 27421780
Asian J Urol. 2015 Oct;2(4):194-201
pubmed: 29264145
Arab J Urol. 2019 May 15;17(2):132-137
pubmed: 31285925
Eur Urol. 2012 Aug;62(2):246-55
pubmed: 22487016
J Endourol. 2014 Oct;28(10):1188-91
pubmed: 24745371
Urol Res. 2012 Oct;40(5):523-9
pubmed: 22160282
J Urol. 1998 Dec;160(6 Pt 1):1975-8
pubmed: 9817303
J Endourol. 2009 Sep;23(9):1437-42
pubmed: 19698053
J Endourol. 2007 May;21(5):499-503
pubmed: 17523902
Arch Ital Urol Androl. 2019 Jan 18;90(4):265-269
pubmed: 30655638
J Urol. 1967 May;97(5):840-4
pubmed: 6025928
Zhonghua Wai Ke Za Zhi. 2013 Oct;51(10):922-7
pubmed: 24433773
J Urol. 1995 Jun;153(6):1817-9
pubmed: 7752325
J Urol. 2011 Feb;185(2):542-7
pubmed: 21168868
Eur Urol. 2008 Jul;54(1):196-202
pubmed: 18262711
Eur Urol. 2008 Dec;54(6):1393-403
pubmed: 18715696
Urology. 2001 Oct;58(4):526-31
pubmed: 11597531
J Endourol. 2009 Mar;23(3):409-15
pubmed: 19265471
Medicina (Kaunas). 2019 Feb 26;55(3):
pubmed: 30813602
Eur Urol. 2012 Jan;61(1):164-70
pubmed: 21570174
Mymensingh Med J. 2018 Jan;27(1):149-158
pubmed: 29459607
J Endourol. 2007 Jun;21(6):628-32
pubmed: 17638560

Auteurs

Roberto Iglesias Lopes (RI)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.
Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, SP, Brasil.

Rodrigo Perrella (R)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.

Carlos Hirokatsu Watanabe (CH)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.

Fabricio Beltrame (F)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.

Alexandre Danilovic (A)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.
Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, SP, Brasil.

Claudio Bovolenta Murta (CB)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.

Joaquim Francisco de Almeida Claro (JFA)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.

Fabio Carvalho Vicentini (FC)

Divisão de Urologia, Hospital Brigadeiro, São Paulo, SP, Brasil.
Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, SP, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH